What is the appropriate evaluation and management for a swelling over the left nipple?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Evaluation and Management of Swelling Over the Left Nipple

Begin with ultrasound as the initial imaging modality for a swelling over the left nipple, regardless of age, as it has the highest sensitivity for detecting both palpable masses and underlying malignancy in symptomatic breast presentations.

Initial Clinical Assessment

First, determine whether this represents a true discrete mass versus diffuse thickening or nodularity. Key distinguishing features to assess:

  • True mass characteristics: Asymmetric compared to the right breast, distinct from surrounding tissue, three-dimensional, and persists across menstrual cycles
  • Associated symptoms: Presence of nipple discharge (spontaneous, unilateral, single-duct, bloody or serous), skin changes, nipple retraction, or pain
  • Patient demographics: Age, lactation status, recent trauma, and breast cancer risk factors

Critical pitfall: Do not perform needle biopsy before imaging, as post-biopsy changes can obscure or alter imaging interpretation 1, 2.

Age-Stratified Imaging Algorithm

For Patients Under Age 30

Start with targeted ultrasound of the palpable area 2:

  • If ultrasound shows a simple cyst, benign lymph node, or clearly benign finding (BI-RADS 1-2): Clinical follow-up only, no further imaging needed 2
  • If ultrasound is negative (BI-RADS 1) with low clinical suspicion: Observe for 1-2 menstrual cycles. If stable or resolved, return to routine care. If enlarging or increasing suspicion, add diagnostic mammography 1
  • If ultrasound shows a suspicious finding (BI-RADS 4-5): Proceed to image-guided core needle biopsy. Add diagnostic mammography to evaluate for additional disease and microcalcifications 2

For Patients Age 30-39

Either ultrasound or diagnostic mammography can be the initial study, though ultrasound sensitivity is higher (95.7% vs 60.9%) for this age group 3, 4:

  • Practical approach: Start with ultrasound, add mammography if any abnormality detected or if clinical suspicion remains high
  • Mammography has value for detecting suspicious microcalcifications associated with DCIS 3
  • Follow same management pathway as younger patients based on BI-RADS category

For Patients Age 40 and Over

Diagnostic mammography (or digital breast tomosynthesis) plus targeted ultrasound 2:

  • Perform both modalities as complementary studies
  • Mammography sensitivity alone is 86-91% for palpable abnormalities 2
  • Ultrasound identifies mammographically occult lesions and definitively characterizes certain findings 2
  • The combination has a negative predictive value of 97.4-100% 2

For Male Patients

Diagnostic mammography starting at age 25 as the initial study, followed by ultrasound 3, 4:

  • Males with nipple symptoms have 23-57% risk of breast cancer 3
  • This represents significantly higher risk than female patients

Management Based on Imaging Results

BI-RADS 1-2 (Negative or Benign)

  • Clinical follow-up without imaging surveillance
  • Return to routine screening schedule
  • No biopsy indicated 2

BI-RADS 3 (Probably Benign)

  • Short-interval follow-up imaging at 6 months
  • If stable, continue surveillance or return to routine care based on clinical context 1

BI-RADS 4-5 (Suspicious or Highly Suggestive of Malignancy)

Perform image-guided core needle biopsy (not fine needle aspiration):

  • Core biopsy is superior to FNA for sensitivity, specificity, and histologic grading 3, 2, 4
  • Use ultrasound guidance when lesion visible on ultrasound (preferred for patient comfort, real-time visualization, no radiation) 2
  • Use stereotactic or tomosynthesis guidance for mammographic-only findings
  • Place marker clip at biopsy site 2

Special Considerations

If Imaging is Negative but Clinical Suspicion Remains High

Never let negative imaging override a highly suspicious clinical finding 2:

  • Consider MRI for problem-solving in select cases
  • Maintain close clinical follow-up with repeat imaging in 3-6 months
  • Surgical consultation may be appropriate for persistently suspicious palpable findings despite negative imaging

If Associated with Nipple Discharge

The presence of pathologic nipple discharge (spontaneous, unilateral, single-duct, bloody or serous) increases malignancy risk to 5-21% 3:

  • Follow the imaging algorithm above based on age
  • If imaging is negative (BI-RADS 1-3), options include: duct excision or close follow-up with physical exam and imaging every 6 months for 1-2 years 1
  • MRI or ductography may be considered to guide surgical planning if duct excision is chosen 1

Inflammatory Changes

If the swelling is associated with erythema, warmth, or skin changes:

  • In lactating patients: Likely mastitis, treat promptly and follow closely. Failure to respond suggests abscess requiring drainage 5
  • In non-lactating patients: View with high suspicion—inflammatory breast cancer must be excluded 5
  • Persistent eczematous changes of the nipple unresponsive to topical treatment should raise concern for Paget's disease 6

Key Pitfalls to Avoid

  1. Do not biopsy before imaging - this alters interpretation 1, 2
  2. Do not rely on physical examination alone - even experienced examiners have only 73% agreement on need for biopsy 2
  3. Do not use FNA instead of core biopsy - core biopsy provides superior diagnostic accuracy 3, 2, 4
  4. Do not dismiss persistent symptoms in males - they have much higher malignancy rates 3
  5. Do not assume all nipple swelling in young women is benign - 1.9% of women age 30-39 with focal symptoms have malignancy 3

References

Guideline

breast cancer screening and diagnosis, version 3.2018, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2018

Guideline

acr appropriateness criteria<sup>®</sup> palpable breast masses.

Journal of the American College of Radiology, 2017

Guideline

acr appropriateness criteria<sup>®</sup> evaluation of nipple discharge.

Journal of the American College of Radiology, 2017

Guideline

acr appropriateness criteria® evaluation of nipple discharge: 2022 update.

Journal of the American College of Radiology, 2022

Research

Inflammation of the breast.

Obstetrics and gynecology clinics of North America, 2002

Research

Mammary Paget's Disease of the Nipple: A Case Report.

Case reports in oncology, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.